Could muscle loss predict dangerous bleeds in seniors on blood thinners?
NCT ID NCT07173075
Summary
This study aims to understand if having less muscle mass is linked to a higher chance of serious bleeding in people aged 70 and older who are taking common blood-thinning medications (like Apixaban or Rivaroxaban). Researchers will compare the muscle mass of 110 participants—some who have had a bleeding event and some who have not—using a simple, painless body scan. The goal is to gather information that could help doctors better assess bleeding risks for elderly patients in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.